肺部超声整合用于非重症COVID-19患者评估
前瞻性观察性研究纳入西班牙三级医院急诊科2020年3—4月确诊SARS-CoV-2非重症呼吸病患者88例,比较使用与未使用肺部超声两队列出院后30天内再入院、急诊复诊及门诊随访天数。使用肺部超声与更高住院概率相关(OR 5.63,95%CI 3.31–9.57,P<0.001),但与死亡率或短期并发症无显著关联;作者认为肺部超声可识别其他常规检查无异常的非重症肺受累患者,但未显示预后价值,仍需更多研究证明其明确获益。
要点
- 非重症COVID-19患者肺部超声最常见受累区为后基底区,表现为局灶性及融合性B线(82.5%)。
- 同区域胸膜不规则见于70.4%的超声评估患者。
- 使用肺部超声与更高住院概率相关(OR 5.63,95%CI 3.31–9.57,P<0.001),但与死亡率或短期并发症无显著关联。
关键影像表现/征象
- 82.5%的超声评估患者最常受累区域为后基底区,表现为局灶性及融合性B线。
- 70.4%的超声评估患者在后基底区同区域显示胸膜不规则。
诊断标准与关键数值
- 使用肺部超声与更高住院概率相关(OR 5.63,95%CI 3.31–9.57,P<0.001)。
- 使用肺部超声与死亡率或短期并发症无显著关联。
临床应用与阅片要点
- 作者认为肺部超声可识别其他常规检查无异常的SARS-CoV-2非重症肺受累患者。
- 作者指出肺部超声在这些患者中未显示预后价值,且可能产生更高比例住院。
- 作者结论为仍需更多研究证明该用途的明确获益。
局限性
- 原文结论指出仍需更多研究证明该用途的明确获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Performing lung ultrasound during the clinical assessment of patients with suspicion of noncritical COVID-19 may increase the diagnostic rate of pulmonary involvement over other diagnostic techniques used in routine clinical practice. This study aims to compare complications (readmissions, emergency department [ED] visits, and length of outpatient follow-up) in the first 30 days after ED discharge in patients with confirmed COVID-19 who were managed with versus without lung ultrasound.
MATERIALS AND METHODS: Prospective, observational, analytical study in noncritical patients with confirmed respiratory disease due to SARS-CoV-2, assessed in the ED of a tertiary Spanish hospital in March and April 2020. We compared 2 cohorts, differentiated by the use of lung ultrasound as a diagnostic tool. Complications were assessed (hospital admissions, ED revisits and days of outpatient follow-up) at 30 days postdischarge.
RESULTS: Of the 88 included patients, 31% (n = 27) underwent an initial lung ultrasound, while 61 (68%) did not. In 82.5% of the patients evaluated with ultrasound, the most predominant areas affected were the posterobasal regions, in the form of focalized and confluent B-lines; 70.4% showed pleural irregularity in these same areas. Use of the lung ultrasound was associated with a greater probability of hospital admission (odds ratio 5.63, 95% confidence interval 3.31 to 9.57; p < 0.001). However, it was not significantly associated with mortality or short-term complications.
CONCLUSIONS: Lung ultrasound could identify noncritical patients with lung impairment due to SARS-CoV-2, in whom other tests used routinely show no abnormalities. However, it has not shown a prognostic value in these patients and could generate a higher percentage of hospital admissions. More studies are still needed to demonstrate the clear benefit of this use.
引用
- Gil-Rodrigo A, Llorens P, Luque-Hernández MJ, et al. Lung Ultrasound Integration in Assessment of Patients with Noncritical COVID-19. J Ultrasound Med. 2021. PMID: 33426645. doi:10.1002/jum.15613
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。